Canadian Lipid Guidelines Update

faculty

J. Robin Conway, MD, PhD Canadian Centre for Research on Diabetes Smiths Falls, ON

Jacques Genest, MD McGill University Montr?al, QC

Rafik Habib, MD Centre cardiovasculaire de Laval Laval, QC

Lawrence Leiter, MD St. Michael's Hospital University of Toronto Toronto, ON

Expert Opinions is published by E.O.C.I. Pharmacomm Ltd.

Volume 1, number 10

For more information please contact

info@

Canadian Lipid Guidelines Update

Publications Mail Agreement Number 40816046 Canada Post: Please return undeliverable mail blocks to: PTM Health, 20 Torbay Road, Markham, ON L3R 1G6

Update on lipid management in Canada Since the last publication of recommendations for the management and treatment of dyslipidemia,1,2 important new clinical data has emerged to support more intensive lipid lowering in certain patient groups. Recent studies in subjects with both stable coronary artery disease (CAD) as well as in those with an acute coronary syndrome (ACS), such as the Treatment to New Targets (TNT),3 Incremental Decrease in Endpoints through Aggressive Lipid Lowering (IDEAL)4 and PRavastatin Or atorVastatin Evaluation and Infection Therapy (PROVE-IT)5 studies have shown that lowering LDL-cholesterol more intensively, to a value of at least ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download